Publication:
Accelerated telomere attrition in children and teenagers with α1-antitrypsin deficiency.

dc.contributor.authorEscribano, Amparo
dc.contributor.authorPastor, Sara
dc.contributor.authorReula, Ana
dc.contributor.authorCastillo, Silvia
dc.contributor.authorVicente, Silvia
dc.contributor.authorSanz, Francisco
dc.contributor.authorCasas, Francisco
dc.contributor.authorTorres, María
dc.contributor.authorFernández-Fabrellas, Estrella
dc.contributor.authorCodoñer-Franch, Pilar
dc.contributor.authorDasí, Francisco
dc.date.accessioned2023-01-25T08:34:08Z
dc.date.available2023-01-25T08:34:08Z
dc.date.issued2016-07-07
dc.description.abstractNumerous studies have shown that oxidative stress accelerates telomere shortening in several lung pathologies. Since oxidative stress is involved in the pathophysiology of α1-antitrypsin deficiency (AATD), we hypothesised that telomere shortening would be accelerated in AATD patients. This study aimed to assess telomere length in AATD patients and to study its association with α1-antitrypsin phenotypes.Telomere length, telomerase activity, telomerase reverse transcriptase (hTERT) expression and biomarkers of oxidative stress were measured in 62 children and teenagers (aged 2-18 years) diagnosed with AATD and 18 controls (aged 3-16 years).Our results show that intermediate-risk (MZ; SZ) and high-risk (ZZ) AATD patients have significantly shorter telomeres and increased oxidative stress than controls. Correlation studies indicate that telomere length was related to oxidative stress markers in AATD patients. Multiple hypothesis testing revealed an association between telomere length, telomerase activity, hTERT expression and AATD phenotypes; high-risk patients showed shorter telomeres, lower hTERT expression and decreased telomerase activity than intermediate-risk and low-risk patients.AATD patients show evidence of increased oxidative stress leading to telomere attrition. An association between telomere and α1-antitrypsin phenotypes is observed suggesting that telomere length could be a promising biomarker for AATD disease progression.
dc.identifier.doi10.1183/13993003.00176-2016
dc.identifier.essn1399-3003
dc.identifier.pmid27390278
dc.identifier.unpaywallURLhttps://erj.ersjournals.com/content/erj/48/2/350.full.pdf
dc.identifier.urihttp://hdl.handle.net/10668/10251
dc.issue.number2
dc.journal.titleThe European respiratory journal
dc.journal.titleabbreviationEur Respir J
dc.language.isoen
dc.organizationHospital Universitario San Cecilio
dc.page.number350-8
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rights.accessRightsopen access
dc.subject.meshAdolescent
dc.subject.meshBody Mass Index
dc.subject.meshCase-Control Studies
dc.subject.meshChild
dc.subject.meshChild, Preschool
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshLung
dc.subject.meshMale
dc.subject.meshOxidative Stress
dc.subject.meshPhenotype
dc.subject.meshSpirometry
dc.subject.meshTelomerase
dc.subject.meshTelomere
dc.subject.meshTelomere Shortening
dc.subject.meshalpha 1-Antitrypsin Deficiency
dc.titleAccelerated telomere attrition in children and teenagers with α1-antitrypsin deficiency.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number48
dspace.entity.typePublication

Files